Alternatives to Alloy Therapeutics

Global supplier of life science research tools, including antibodies, reagents, and assays.

AI-guided drug discovery platform for tissue-targeted medicines.

Life science company pioneering drug discovery with AI and advanced technologies.

A global contract research organization specializing in preclinical and translational oncology research.

Developer and manufacturer of antibodies and reagents for biomedical research.

Biotechnology services company specializing in antibody discovery and development.

CDMO providing process development, analytical services, and cGMP API manufacturing for drug candidates.

Biotechnology firm specializing in antibody development, production, and biological research tools.

Drug discovery services company specializing in small molecule drug discovery and medicinal chemistry.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Developing gene editing therapies to lower cholesterol.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Advancing next-generation mRNA medicines.

A biotechnology company focused on oncology drug discovery.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Biotech company developing novel drug delivery technologies.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Developing disease-responsive advanced therapies through programmable gene control technology.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A vertically-integrated procurement platform for the life sciences industry.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Enzyme-based technology to break down alcohol in the stomach.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Developing novel immunotherapies and diagnostics for cancer.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

AI-powered knowledge discovery for life sciences.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Engineering scalable gene therapies for broader patient populations.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.